Every 8-K that Acme United Corporation (ACU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ACU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACU filings page.
Acme United Corporation reported strong second quarter 2026 results, with net sales of $62.7 million, up 16% from a year earlier, and net income of $5.1 million, up 6%. Diluted EPS was $1.22 and gross margin improved to 42.6% from 41.0%.
For the first six months of 2026, net sales rose to $115.0 million, up 15%, while net income was $6.0 million and diluted EPS $1.46, both below the prior year, reflecting a 6% decline in net income and 7% decline in diluted earnings per share caused primarily by first quarter results. The My Medic acquisition and a German cutting and sharpening product line contributed to growth.
U.S. segment sales grew 17% in the quarter, Europe rose 24% in U.S. dollars, and Canada increased 1%. Bank debt less cash was $27.3 million, and the company entered into a new $65 million syndicated credit facility maturing July 15, 2029 to replace its prior facility. Management noted that high tariffs will continue to pressure margins, but at a decreasing rate, and expects My Medic profitability to remain weighted to the fourth quarter.
Acme United Corporation entered into a new $65 million syndicated credit facility with HSBC Bank USA, National Association, and City National Bank, replacing its prior $65 million facility with HSBC. The facility is intended to provide liquidity for growth, acquisitions, dividends, and other business activities and expires on July 15, 2029.
Borrowings bear interest at Term SOFR plus an applicable margin of 2.00%–2.75%, based on the company’s Net Funded Debt to EBITDA ratio, with a 0.25% per annum commitment fee on unused commitments. The facility is secured by a first-priority lien on substantially all company assets and includes quarterly covenants capping Net Funded Debt to EBITDA at 3.75 to 1.00 and requiring a minimum Fixed Charge Coverage Ratio of 1.10 to 1.00. On July 15, 2026, the opening balance was $28.5 million, equal to the payoff of the former credit facility.
ACME United Corporation reported the results of its 2026 Annual Meeting of Shareholders held on April 27, 2026. Shareholders elected all seven director nominees, each receiving over 2.82 million votes for, with relatively few votes withheld.
Investors approved an amendment to the 2022 Employee Stock Option Plan with 1,951,474 votes for and 925,794 against, and supported a non-binding advisory resolution on named executive officer compensation with 2,775,611 votes for and 102,051 against. Shareholders also ratified the appointment of CBIZ CPA's, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 3,413,803 votes in favor.
Acme United Corporation reported higher sales but lower profits for the quarter ended March 31, 2026. Net sales rose to $52.3 million from $46.0 million a year earlier, a 14% increase, or 6% growth excluding the My Medic acquisition.
Net income declined to $1.0 million, or $0.24 per diluted share, from $1.7 million, or $0.41 per diluted share, as higher cost of sales and operating expenses offset revenue gains. The company cited tariff-related costs, enhanced quality assurance spending at the Med-Nap facility, and rising employee healthcare costs as key drivers.
Acme highlighted contributions from the recently acquired My Medic business, which has annual sales of $19 million but minimal first-quarter profit due to seasonality. U.S., European, and Canadian segments all posted double-digit sales growth in U.S. dollars. Bank debt less cash increased to $38.6 million, reflecting the My Medic acquisition, a German product line purchase, dividends, a new Tennessee facility, and inventory builds to mitigate supply risks from the conflict in Iran.
Acme United Corporation reported modest sales growth but stronger earnings for 2025 and the fourth quarter. Net sales for Q4 2025 rose to $47.5 million from $45.9 million, while net income increased to $1.9 million, or $0.46 per diluted share, up 12% per share from 2024.
For the full year 2025, net sales edged up to $196.5 million from $194.5 million. Net income was $10.2 million, or $2.49 per diluted share, slightly above 2024. The company highlighted tariff-related uncertainty that hurt some U.S. retail promotions but noted strong first aid product sales, robust growth in Europe and Canada, and stable gross margins.
Acme acquired My Medic in January 2026, a tactical and emergency response products business with approximately $19 million in 2025 revenues for a purchase price of $18.7 million. Bank debt less cash fell to $18.1 million as of December 31, 2025, helped by about $13.6 million in free cash flow and investment in a new $6 million Tennessee facility.
Acme United Corporation completed an asset acquisition from SLED Distribution, LLC d/b/a "My Medic" and Rapid Medical, LLC, buying substantially all assets of their emergency and first aid products business. The maximum purchase price for the acquired assets is $18,700,000, including $14.6 million paid in cash at closing.
An additional $1,000,000 is contingent on achieving specified revenue milestones during the twelve months ended December 31, 2027, and $3.1 million is subject to a holdback primarily to cover potential indemnification claims. Acme acquired inventory, receivables, equipment, intellectual property, customer and supplier relationships, and certain contracts, while excluding cash, certain contracts, and other non-core items, and only assumed limited specified liabilities. The agreement includes customary representations, warranties, covenants, and indemnification provisions and is governed by Utah law.
Acme United Corporation filed a Form 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025. The company furnished the release as Exhibit 99.1.
The filing lists Item 2.02 (Results of Operations and Financial Condition) and includes the press release dated October 21, 2025. Acme United’s common stock trades on the NYSE American under the symbol ACU.